Advertisement

Radiotherapy

  • Kate E. BurtonEmail author
Chapter

Abstract

The majority of adult patients diagnosed with a primary brain tumour will receive radiotherapy as part of their management plan. This chapter aims to explore what radiotherapy is and define the various forms of radiotherapy used in the treatment of gliomas. It will give an overview of the factors involved in patient selection for different tumour grades and describe the typical radiotherapy planning and treatment pathway.

The potential acute and long-term toxicity from radiotherapy to the brain will be addressed and appropriate management and support for patient undergoing treatment described.

Keywords

Radiotherapy Glioma treatment Brain tumour treatments Concomitant RT Adjuvant RT Radiotherapy side effects 

References

  1. 1.
    Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.CrossRefGoogle Scholar
  2. 2.
    Buckner JC, Shaw EG, Pugh SL, et al. Radiation plus procarbazine, CCNU and vincristine in low-grade gliomas. N Engl J Med. 2016;374(14):1344–55.CrossRefGoogle Scholar
  3. 3.
    Perry JR, Laperriere N, O’Callaghan CJ, et al. Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med. 2017;376(11):1027–37.CrossRefGoogle Scholar
  4. 4.
    Ncri.org. Clinical and translational radiotherapy research working group (CTRad) Proton beam therapy – information for a lay audience [Internet]. 2016. http://ctrad.ncri.org.uk/wp-content/uploads/2014/01/CTRad-PBT-consumer-information-Jan-2016.pdf. Accessed 29 Oct 2017.
  5. 5.
    Combs SE. Does proton therapy have a future in CNS tumors? Curr Treat Options Neurol. 2017;19(3):12.CrossRefGoogle Scholar
  6. 6.
    Harrabi SB, Bougatf N, Mohr A, et al. Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma. Strahlenther Onkol. 2016;192(11):759–69.CrossRefGoogle Scholar
  7. 7.
    Kleihues P, Cavenee WK, editors. World Health Organisation classification of tumours, pathology and genetics of tumours of the nervous system. Lyon: IARC Press International Agency for Research on Cancer; 2000.Google Scholar
  8. 8.
    Van den Bent MJ, Brandes AA, Taphoorn MJ, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol. 2013;31(3):344–50.CrossRefGoogle Scholar
  9. 9.
    Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013;31(3):337–43.CrossRefGoogle Scholar
  10. 10.
    Van den Bent MJ, Baumert B, Erridge S, et al. Interim results from the CATNON trial (EORTC study 26053–22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Lancet. 2017;  https://doi.org/10.1016/S0140–6736(17)31442–3.
  11. 11.
    Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Rad Oncol Biol Phys. 2002;52(2):316–24.CrossRefGoogle Scholar
  12. 12.
    Fox SW, Lyon D, Farace E. Symptom clusters in patients with high-grade gliomas. J Nurs Scholarsh. 2007;39(1):61–7.CrossRefGoogle Scholar
  13. 13.
    Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;2012(11):Art. No.: CD006145.  https://doi.org/10.1002/14651858.CD006145.pub3.CrossRefGoogle Scholar
  14. 14.
    Faithful S, Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumours. Clin Oncol (R Coll Radiol). 1998;10(4):250–4.CrossRefGoogle Scholar
  15. 15.
    Nih.gov. Common terminology criteria for adverse events (CTCAE) V4.03 [Internet]. 2010. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed 29 Oct 2017.
  16. 16.
    Westbury C, Hines F, Hawkes E, et al. Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. Radiother Oncol. 2000;54:109–16.CrossRefGoogle Scholar
  17. 17.
    Society and College of Radiographers. Skin care advice for patients undergoing radical external beam megavoltage radiotherapy. SCoR professional document [Internet]. 2015. https://www.sor.org/learning/document-library/skin-care-advice-patients-undergoing-radical-external-beam-megavoltage-radiotherapy-0. Accessed 25 Oct 2017.
  18. 18.
    Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 2002;360(9343):1361–8. Erratum in: Lancet 2011;377(9778):1654).CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Oncology Centre, Addenbrooke’s HospitalCambridge University Hospitals NHS Foundation TrustCambridgeUK

Personalised recommendations